 | Up a level |
Journal Article
Giugliano, Robert P., Pedersen, Terje R., Park, Jeong-Gun, De Ferrari, Gaetano M., Gaciong, Zbigniew A., Ceska, Richard, Toth, Kalman, Gouni-Berthold, Ioanna, Lopez-Miranda, Jose 
ORCID: 0000-0002-8844-0718, Schiele, Francois, Mach, Francois, Ott, Brian R., Kanevsky, Estelle, Pineda, Armando Lira, Somaratne, Ransi, Wasserman, Scott M., Keech, Anthony C., Sever, Peter S. and Sabatine, Marc S.
(2017).
Clinical efficacy and safety of achieving very low LDL-cholesterol concentrations with the PCSK9 inhibitor evolocumab: a prespecified secondary analysis of the FOURIER trial.
Lancet, 390 (10106).
S. 1962 - 1972.
NEW YORK:
ELSEVIER SCIENCE INC.
ISSN 1474-547X
Nissen, Steven E., Dent-Acosta, Ricardo E., Rosenson, Robert S., Stroes, Erik, Sattar, Naveed, Preiss, David ORCID: 0000-0003-3139-1836, Mancini, John, Ballantyne, Christie M., Catapano, Alberico, Gouni-Berthold, Ioanna, Stein, Evan A., Xue, Allen, Wasserman, Scott M., Scott, Rob and Thompson, Paul D.
(2016).
Comparison of PCSK9 Inhibitor Evolocumab vs Ezetimibe in Statin-Intolerant Patients: Design of the Goal Achievement After Utilizing an Anti-PCSK9 Antibody in Statin-Intolerant Subjects 3 (GAUSS-3) Trial.
Clin. Cardiol., 39 (3).
S. 137 - 145.
HOBOKEN:
WILEY-BLACKWELL.
ISSN 1932-8737
Nissen, Steven E., Stroes, Erik, Dent-Acosta, Ricardo E., Rosenson, Robert S., Lehman, Sam J., Sattar, Naveed, Preiss, David ORCID: 0000-0003-3139-1836, Bruckert, Eric, Ceska, Richard ORCID: 0000-0002-2541-5179, Lepor, Norman, Ballantyne, Christie M., Gouni-Berthold, Ioanna, Elliott, Mary, Brennan, Danielle M., Wasserman, Scott M., Somaratne, Ransi, Scott, Rob and Stein, Evan A.
(2016).
Efficacy and Tolerability of Evolocumab vs Ezetimibe in Patients With Muscle-Related Statin Intolerance The GAUSS-3 Randomized Clinical Trial.
JAMA-J. Am. Med. Assoc., 315 (15).
S. 1580 - 1591.
CHICAGO:
AMER MEDICAL ASSOC.
ISSN 1538-3598
O'Donoghue, Michelle L., Fazio, Sergio, Giugliano, Robert P., Stroes, Erik S. G., Kanevsky, Estella, Gouni-Berthold, Ioanna, Im, KyungAh, Pineda, Armando Lira, Wasserman, Scott M., Ceska, Richard, Ezhov, Marat V., Jukema, J. Wouter, Jensen, Henrik K., Tokgozoglu, S. Lale, Mach, Francois, Huber, Kurt, Sever, Peter S., Keech, Anthony C., Pedersen, Terje R. and Sabatine, Marc S. (2019). Lipoprotein(a), PCSK9 Inhibition, and Cardiovascular Risk Insights From the FOURIER Trial. Circulation, 139 (12). S. 1483 - 1493. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. ISSN 1524-4539
Raal, Frederick J., Stein, Evan A., Dufour, Robert, Turner, Traci, Civeira, Fernando, Burgess, Lesley, Langslet, Gisle, Scott, Russell ORCID: 0000-0002-2107-6480, Olsson, Anders G., Sullivan, David, Hovingh, G. Kees, Cariou, Bertrand ORCID: 0000-0002-1580-8040, Gouni-Berthold, Ioanna, Somaratne, Ransi, Bridges, Ian, Scott, Rob, Wasserman, Scott M. and Gaudet, Daniel
(2015).
PCSK9 inhibition with evolocumab (AMG 145) in heterozygous familial hypercholesterolaemia (RUTHERFORD-2): a randomised, double-blind, placebo-controlled trial.
Lancet, 385 (9965).
S. 331 - 341.
NEW YORK:
ELSEVIER SCIENCE INC.
ISSN 1474-547X
Stroes, Erik, Dent, Ricardo, Rosenson, Robert S., Thompson, Paul D., Ballantyne, Christie M., Gouni-Bertholds, Loanna, Hsu, Yi-Hsiang, Davis, Michael, Wasserman, Scott M. and Nissen, Steven E. (2016). A Genome-wide Association Study (GWAS) Identifies Novel Loci Associated With Clinically Defined Statin-Associated Muscle Symptoms in a Double-Blind Cross-Over Re-challenge Trial. Circulation, 134 (25). S. E710 - 2. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. ISSN 1524-4539